IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
Status:
Completed
Trial end date:
2019-07-24
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and efficacy of intravenous (iv) or
iv/per oral (po) omadacycline as compared to iv or iv/po levofloxacin in the treatment of
female adults with acute pyelonephritis.